BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20357745)

  • 1. Roles of prostanoids in the pathogenesis of cardiovascular diseases.
    Yuhki K; Kashiwagi H; Kojima F; Kawabe J; Ushikubi F
    Int Angiol; 2010 Apr; 29(2 Suppl):19-27. PubMed ID: 20357745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
    Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
    Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological roles of the prostanoids in the cardiovascular system: studies using mice deficient in prostanoid receptors].
    Hara A; Yuhki K; Fujino T; Narumiya S; Ushikubi F
    Nihon Yakurigaku Zasshi; 2003 Nov; 122(5):384-90. PubMed ID: 14569157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia.
    Takayama K; Yuhki K; Ono K; Fujino T; Hara A; Yamada T; Kuriyama S; Karibe H; Okada Y; Takahata O; Taniguchi T; Iijima T; Iwasaki H; Narumiya S; Ushikubi F
    Nat Med; 2005 May; 11(5):562-6. PubMed ID: 15834430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors.
    Xiao CY; Hara A; Yuhki K; Fujino T; Ma H; Okada Y; Takahata O; Yamada T; Murata T; Narumiya S; Ushikubi F
    Circulation; 2001 Oct; 104(18):2210-5. PubMed ID: 11684633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prostaglandins and thromboxane A2 on coronary vessel tone--mechanisms of action and therapeutic implications.
    Schrör K
    Eur Heart J; 1993 Nov; 14 Suppl I():34-41. PubMed ID: 7507439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
    Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
    Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of the prostanoids played in the body].
    Ushikubi F; Narumiya S
    Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):201-7. PubMed ID: 11979724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
    Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of prostanoids in the kidney--studies using mice deficient in prostanoid receptors].
    Fujino T; Hasebe N; Kikuchi K; Ushikubi F
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():203-8. PubMed ID: 16523888
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors.
    Ushikubi F; Sugimoto Y; Ichikawa A; Narumiya S
    Jpn J Pharmacol; 2000 Aug; 83(4):279-85. PubMed ID: 11001172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
    Smith EF
    Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented cardiac hypertrophy in response to pressure overload in mice lacking the prostaglandin I2 receptor.
    Hara A; Yuhki K; Fujino T; Yamada T; Takayama K; Kuriyama S; Takahata O; Karibe H; Okada Y; Xiao CY; Ma H; Narumiya S; Ushikubi F
    Circulation; 2005 Jul; 112(1):84-92. PubMed ID: 15983244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
    Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
    Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin II type 2 receptor in cardiovascular disease.
    Lemarié CA; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):19-31. PubMed ID: 19861349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
    Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells.
    Klein-Nulend J; Burger EH; Semeins CM; Raisz LG; Pilbeam CC
    J Bone Miner Res; 1997 Jan; 12(1):45-51. PubMed ID: 9240724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and vascular function.
    Weksler BB
    Circulation; 1984 Nov; 70(5 Pt 2):III63-71. PubMed ID: 6386223
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
    Hata AN; Breyer RM
    Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.